Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

472 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer.
Kaufmann M, Jonat W, Blamey R, Cuzick J, Namer M, Fogelman I, de Haes JC, Schumacher M, Sauerbrei W; Zoladex Early Breast Cancer Research Association (ZEBRA) Trialists' Group. Kaufmann M, et al. Among authors: fogelman i. Eur J Cancer. 2003 Aug;39(12):1711-7. doi: 10.1016/s0959-8049(03)00392-7. Eur J Cancer. 2003. PMID: 12888366 Clinical Trial.
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
Jonat W, Kaufmann M, Sauerbrei W, Blamey R, Cuzick J, Namer M, Fogelman I, de Haes JC, de Matteis A, Stewart A, Eiermann W, Szakolczai I, Palmer M, Schumacher M, Geberth M, Lisboa B; Zoladex Early Breast Cancer Research Association Study. Jonat W, et al. Among authors: fogelman i. J Clin Oncol. 2002 Dec 15;20(24):4628-35. doi: 10.1200/JCO.2002.05.042. J Clin Oncol. 2002. PMID: 12488406
Breast cancer and osteoporosis--a bridge at last.
Fentiman IS, Fogelman I. Fentiman IS, et al. Among authors: fogelman i. Eur J Cancer. 1993;29A(4):485-6. doi: 10.1016/s0959-8049(05)80135-2. Eur J Cancer. 1993. PMID: 8435196 No abstract available.
Tamoxifen protects against steroid-induced bone loss.
Fentiman IS, Saad Z, Caleffi M, Chaudary MA, Fogelman I. Fentiman IS, et al. Among authors: fogelman i. Eur J Cancer. 1992;28(2-3):684-5. doi: 10.1016/s0959-8049(05)80125-x. Eur J Cancer. 1992. PMID: 1591093 Clinical Trial.
Significant differences in UK and US female bone density reference ranges.
Noon E, Singh S, Cuzick J, Spector TD, Williams FM, Frost ML, Howell A, Harvie M, Eastell R, Coleman RE, Fogelman I, Blake GM; IBIS-II Bone Substudy. Noon E, et al. Among authors: fogelman i. Osteoporos Int. 2010 Nov;21(11):1871-80. doi: 10.1007/s00198-009-1153-1. Epub 2010 Jan 9. Osteoporos Int. 2010. PMID: 20063090 Free PMC article.
472 results